58.1
Aisling A. Murphy
GlaxoSmithKline (United Kingdom), European Medicines Agency
Aisling A. Murphy has made significant contributions to various fields, including vaccine development, virology, and animal science. Research on cytomegalovirus-based vaccines expressing Ebola virus glycoprotein offers promise for protection against Ebola infection in nonhuman primates. Additionally, the discovery of a polyomavirus in European badgers sheds light on the evolution of host range within the Polyomaviridae family. Murphy has also investigated the role of DNA sensors, such as Sting, in protecting against lethal infections caused by herpes simplex virus 1. These findings have implications for developing effective vaccines and treatments for emerging infectious diseases like Ebola and HSV-1.
Firms applying this knowledge
University Of Plymouth